Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cidara Thera (CDTX)

Cidara Thera (CDTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cidara Thera 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 USA

P: 858-752-6170

Description:

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 55,096
Shares Outstanding, K 66,686
Annual Sales, $ 12,070 K
Annual Net Income, $ -72,110 K
Last Quarter Sales, $ 7,080 K
Last Quarter Net Income, $ -18,080 K
60-Month Beta 1.07
% of Insider Shareholders 8.03%
% of Institutional Shareholders 47.52%
Float, K 61,331
% Float 91.97%

Growth:

1-Year Return -67.07%
3-Year Return -70.91%
5-Year Return -91.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 44.62%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/24/22
Earnings Per Share ttm -1.07
EPS Growth vs. Prev Qtr -305.56%
EPS Growth vs. Prev Year 9.76%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CDTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.74
Price/Earnings to Growth N/A
Return-on-Equity % -722.37%
Return-on-Assets % -85.70%
Profit Margin % -597.43
Net Margin % N/A
Debt/Equity N/A
Price/Sales 0.85
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar